CD276 and cancer: ADM was found to exhibit a strong and consistent positive correlation with several immune checkpoint genes, including CD274 (PD-L1), CD276, TNFRSF18, TNFSF9, and PVR in the pan-cancer analysis, which contributed to the development of a suppressive immune microenvironment.